Compare Brevis (BREV) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Venom — how do they compare? Brevis trades at Rp1,331 (market cap Rp334,02M, Rp229,47M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Brevis and Venom are close in size by market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Venom for 21 Days on average.
| BREV | VENOM | |
|---|---|---|
Market Cap | Rp334,02M | Rp340,86M |
Volume (24h) | Rp229,47M | Rp2,89M |
Circulating Supply | 250M / 1B BREV (25%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 6 Days | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) shows mixed technical signals with an overall bullish bias despite bearish moving averages. The token trades at Rp1,345.9 with a market cap of Rp333.86 million and 25% circulating supply. Key technical indicators show RSI_6 at 27.08 (oversold) and strong ADX readings suggesting trending momentum. Support levels are established at Rp1,256-Rp1,335 while resistance sits at Rp1,413-Rp1,492.
Overall outlook suggests cautious optimism with oversold RSI signaling potential rebound. Key opportunities include technical bounce from support levels, while major risks involve limited liquidity (Rp333.86M market cap) and absence of recent protocol updates. Investors should monitor volume confirmation for sustained moves.
Venom (VENOM) is a low-circulation cryptocurrency with a market cap of Rp340.86 million and only 13% of its 8 million max supply in circulation. Current price data is unavailable, but the asset shows limited trading activity with a hold time of 21 days, indicating low liquidity and minimal recent market movement. No major protocol updates or ecosystem developments are reported, suggesting stagnant network growth.
Overall outlook is cautious due to low liquidity and limited adoption. Key opportunities include potential price appreciation if circulation increases, but major risks involve high volatility from thin order books and regulatory uncertainty in the crypto space. Investors should monitor exchange listings and on-chain activity for signs of revival.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
